SCHEMBL7327610

SCHEMBL7327610

CN(C)CCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 6/20 0.81
HPGD P15428 4/20 0.73
GABRA1 P14867 5/20 0.68
GABRA5 P31644 5/20 0.68
GABRA2 P47869 5/20 0.68
GABRB2 P47870 4/20 0.68
GABRA3 P34903 3/20 0.68
BRD4 O60885 2/20 0.68
LMNA P02545 2/20 0.68
CNR1 P21554 1/20 0.68
SMN1; SMN2 Q16637 3/20 0.66
RECQL P46063 1/20 0.66
KDM4E B2RXH2 1/20 0.61
PDE4D Q08499 3/20 0.54
GABRG2 P18507 2/20 0.53
GABRB3 P28472 2/20 0.53
ADRA1A P35348 2/20 0.53
HTR2A P28223 1/20 0.53
TDP1 Q9NUW8 1/20 0.52
GABRP O00591 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11825237 0.93 HPGD (0.73) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL11825820 0.93 OPRK1 (0.70) OPRK1HPGDGABRA1GABRA5GABRA2
Cyclohexane SCHEMBL11823207 0.91 OPRK1 (0.68) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL11823022 0.91 OPRK1 (0.73) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL10741552 0.90 OPRK1 (0.71) OPRK1HPGDGABRA1GABRA5GABRA2
Adinazolam SCHEMBL35430 0.89 OPRK1 (1.00) OPRK1HPGDGABRA1GABRA5GABRA2
Adinazolam SCHEMBL29358737 0.89 OPRK1 (1.00) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL7323544 0.89 OPRK1 (0.77) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL11833086 0.89 OPRK1 (0.65) OPRK1HPGDGABRA1GABRA5GABRA2
SCHEMBL11690970 0.89 OPRK1 (0.70) OPRK1HPGDGABRA1GABRA5GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0219541-B1 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES THE UPJOHN COMPANY (US) 1989-09-20 EP claimed
EP-0219541-A1 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES. UPJOHN CO (US) 1987-04-29 EP claimed
WO-1986006631-A2 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES THE UPJOHN COMPANY (US) 1986-11-20 WO claimed
US-4075221-A ALKYLATION WITH DIALKYLMETHYLENEAMMONIUM SALT IN PRESENCE OF REACTIVE CARBOXYLIC ACYLATING AGENT THE UPJOHN COMPANY (US) 1978-02-21 US claimed
US-4012413-A 1-(2-AMINOALKYL)-6-PHENYL-TRIAZOLO-BENZODIAZEPINE COMPOUNDS USED AS TRANQUILIZERS AND ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1977-03-15 US claimed
US-3969504-A 6-Phenyl benzodiazepine antidepressants THE UPJOHN CO. (US) 1976-07-13 US claimed
EP-0219541-B1 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES THE UPJOHN COMPANY (US) 1989-09-20 EP disclosed
EP-0219541-A1 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES. UPJOHN CO (US) 1987-04-29 EP disclosed
WO-1986006631-A2 TREATMENT OF PREMENSTRUAL SYNDROMES USING TRIAZOLOBENZODIAZEPINES THE UPJOHN COMPANY (US) 1986-11-20 WO disclosed
US-4472397-A Use of certain 1-substituted-triazolo-benzodiazepines to treat psychoses THE UPJOHN COMPANY (US) 1984-09-18 US disclosed
US-4075221-A ALKYLATION WITH DIALKYLMETHYLENEAMMONIUM SALT IN PRESENCE OF REACTIVE CARBOXYLIC ACYLATING AGENT THE UPJOHN COMPANY (US) 1978-02-21 US disclosed
US-4012413-A 1-(2-AMINOALKYL)-6-PHENYL-TRIAZOLO-BENZODIAZEPINE COMPOUNDS USED AS TRANQUILIZERS AND ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1977-03-15 US disclosed
US-3994941-A METHYLOLATION, PHTHALIMIDATION THE UPJOHN COMPANY (US) 1976-11-30 US disclosed
US-3994940-A Preparation of 1-(2-(dimethylamino)ethyl)-6-phenyl-4H-5-triazolo(4,3-a)(1,4)benzodiazepines THE UPJOHN COMPANY (US) 1976-11-30 US disclosed
US-3969504-A 6-Phenyl benzodiazepine antidepressants THE UPJOHN CO. (US) 1976-07-13 US disclosed